T-FINDER: A highly sensitive, pan-HLA platform for functional T cell receptor and ligand discovery

Author:

Cetin Miray1ORCID,Pinamonti Veronica12ORCID,Schmid Theresa1ORCID,Boschert Tamara234ORCID,Mellado Fuentes Ana1ORCID,Kromer Kristina12ORCID,Lerner Taga1,Zhang Jing1,Herzig Yonatan1,Ehlert Christopher5,Hernandez-Hernandez Miguel1ORCID,Samaras Georgios1ORCID,Torres Claudia Maldonado1,Fisch Laura12ORCID,Dragan Valeriia12ORCID,Kouwenhoven Arlette6,Van Schoubroeck Bertrand6ORCID,Wils Hans6,Van Hove Carl6ORCID,Platten Michael347ORCID,Green Edward W.37ORCID,Stevenaert Frederik6,Felix Nathan J.8,Lindner John M.1ORCID

Affiliation:

1. BioMed X GmbH, Im Neuenheimer Feld 515, 69120 Heidelberg, Germany.

2. Faculty of Biosciences, Heidelberg University, 69120 Heidelberg, Germany.

3. DKTK CCU Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.

4. Helmoltz Institute for Translational Oncology (HI-TRON), Heidelberg, Germany.

5. Heidelberg Institute for Theoretical Studies (HITS gGmbH), 69118 Heidelberg, Germany.

6. Janssen Research and Development, Beerse, Belgium.

7. Department of Neurology, Medical Faculty Mannheim, MCTN Heidelberg University, Mannheim, Germany.

8. Janssen Research and Development, Spring House, PA, USA.

Abstract

Effective, unbiased, high-throughput methods to functionally identify both class II and class I HLA–presented T cell epitopes and their cognate T cell receptors (TCRs) are essential for and prerequisite to diagnostic and therapeutic applications, yet remain underdeveloped. Here, we present T-FINDER [T cell Functional Identification and (Neo)-antigen Discovery of Epitopes and Receptors], a system to rapidly deconvolute CD4 and CD8 TCRs and targets physiologically processed and presented by an individual’s unmanipulated, complete human leukocyte antigen (HLA) haplotype. Combining a highly sensitive TCR signaling reporter with an antigen processing system to overcome previously undescribed limitations to target expression, T-FINDER both robustly identifies unknown peptide:HLA ligands from antigen libraries and rapidly screens and functionally validates the specificity of large TCR libraries against known or predicted targets. To demonstrate its capabilities, we apply the platform to multiple TCR-based applications, including diffuse midline glioma, celiac disease, and rheumatoid arthritis, providing unique biological insights and showcasing T-FINDER’s potency and versatility.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3